Association between serum uric acid levels and coronary flow reserve in hypertensive patients without concomitant risk factors

Blood Pressure

Volumn 16, Issue 4, 2007, Pages 254-261

  Caliskan, Mustafa ^a   Erdogan, Dogan ^b   Gullu, Hakan ^a   Yildirim, Ibrahim ^a   Ozer, Ismail ^a   Yildirir, Aylin ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Coronary flow reserve; Echo cardiography; Hypertension; Target organ damage; Uric acid

Indexed keywords

CREATININE; LIPID; URIC ACID;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHI SQUARE TEST; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SEX; URIC ACID BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY CIRCULATION; CORONARY VESSELS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MIDDLE AGED; ROC CURVE; URIC ACID;

EID: 35148817079     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050701428240     Document Type: Article

References (38)

1. Regoli, F. and Winston, G. W. (1999) Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals. Toxicol Appl Pharmacol, 156, pp. 96-105.
2. Freedman, D. S., Williamson, D. F., Gunter, E. W. and Byers, T. (1995) Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol, 141, pp. 637-644.
3. Alderman, M. H. (2002) Uric acid and cardiovascular risk. Curr Opin Pharmacol, 2, pp. 126-130.
4. Brand, F. N., McGee, D. L., Kannel, W. B., Stokes, J. and Castelli, W. P. (1985) Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol, 121, pp. 11-18.
5. Fang, J. and Alderman, M. H. (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 283, pp. 2404-2410.
6. Liese, A. D., Hense, H. W., Lowel, H., Doring, A., Tietze, M. and Keil, U. (1999) Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology, 10, pp. 391-397.
7. Alderman, M. H., Cohen, H., Madhavan, S. and Kivlighn, S. (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension, 34, pp. 144-150.
8. Lehto, S., Niskanen, L., Ronnemaa, T. and Laakso, M. (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke, 29, pp. 635-639.
9. Langlois, M., De Bacquer, D., Duprez, D., De Buyzere, M., Delanghe, J. and Blaton, V. (2003) Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis, 168, pp. 163-168.
10. Hoieggen, A., Alderman, M. H., Kjeldsen, S. E., Julius, S., Devereux, R. B., De Faire, U. and LIFE Study Group (2004) The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int, 65, pp. 1041-1049.
11. Johnson, R. J., Kang, D. H., Feig, D., Kivlighn, S., Kanellis, J. and Watanabe, S. (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension, 41, pp. 1183-1190.
12. Laine, H., Raitakari, O. T., Niinikoski, H., Pitkanen, O. P., Iida, H. and Viikari, J. (1998) Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol, 32, pp. 147-153.
13. Schwartzkopff, B., Motz, W., Frenzel, H., Vogt, M., Knauer, S. and Strauer, B. E. (1993) Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation, 88, pp. 993-1003.
14. Frohlich, E. D. (2001) Fibrosis and ischemia: The real risks in hypertensive heart disease. Am J Hypertens, 14, pp. 194S-199S.
15. Brilla, C. G., Janicki, J. S. and Weber, K. T. (1991) Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res, 69, pp. 107-115.
16. Jennings, G. L. and Dilley, R. J. (2002) Left ventricular remodelling impacts on coronary flow reserve in hypertensive patients: Is there a vascular mechanism?. J Hypertens, 20, pp. 1291-1293.
17. Viazzi, F., Parodi, D., Leoncini, G., Parodi, A., Falqui, V. and Ratto, E. (2005) Serum uric acid and target organ damage in primary hypertension. Hypertension, 45, pp. 991-996.
18. Erhardt, J. G., Estes, J. E., Pfeiffer, C. M., Biesalski, H. K. and Craft, N. E. (2004) Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr, 134, pp. 3127-3132.
19. Devereux, R. B. and Reichek, N. (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation, 55, pp. 613-618.
20. Erdogan, D., Gullu, H., Caliskan, M., Yildirim, I., Ulus, T. and Bilgi, M. (2005) Coronary flow reserve in dipper and non-dipper hypertensive patients. Blood Press, 14, pp. 345-352.
21. Caiati, C., Montaldo, C., Zedda, N., Bina, A. and Iliceto, S. (1999) New noninvasive method for coronary flow reserve assessment: Contrast-enhanced transthoracic second harmonic echo Doppler. Circulation, 99, pp. 771-778.
22. Galderisi, M., Cicala, S., Caso, P., De Simone, L., D'Errico, A. and Petrocelli, A. (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol, 90, pp. 860-864.
23. Fessel, W. J. (1980) High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med, 68, pp. 401-404.
24. Campion, E. W., Glynn, R. J. and DeLabry, L. O. (1987) Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med, 82, pp. 421-426.
25. Ward, H. J. (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet, 352, pp. 670-671.
26. Messerli, F. H., Frohlich, E. D., Dreslinski, G. R., Suarez, D. H. and Aristimuno, G. G. (1980) Serum uric acid in essential hypertension: An indicator of renal vascular involvement. Ann Intern Med, 93, pp. 817-821.
27. Verdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C. and Brunetti, P. (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension, 36, pp. 1072-1078.
28. Mattei, P., Arzilli, F., Giovannetti, R., Penno, G., Arrighi, P. and Taddei, S. (1997) Microalbuminuria and renal haemodynamics in essential hypertension. Eur J Clin Invest, 27, pp. 755-760.
29. Khosla, U. M., Zharikov, S., Finch, J. L., Nakagawa, T., Roncal, C. and Mu, W. (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int, 67, pp. 1739-1742.
30. Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V. and Nepomuceno, T. (2005) Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int, 67, pp. 237-247.
31. Erdogan, D., Gullu, H., Caliskan, M., Yildirim, E., Bilgi, M. and Ulus, T. (2005) Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract, 59, pp. 1276-1282.
32. Caiati, C., Zedda, N., Montaldo, C., Montisci, R. and Iliceto, S. (1999) Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: A noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol, 34, pp. 122-130.
33. Saraste, M., Koskenvuo, J., Knuuti, J., Toikka, J., Laine, H. and Niemi, P. (2001) Coronary flow reserve: Measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol, 21, pp. 114-122.
34. Kozakova, M., Palombo, C., Pratali, L., Pittella, G., Galetta, F. and L'Abbate, A. (1997) Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension, 29, pp. 551-559.
35. Opherk, D., Mall, G., Zebe, H., Schwarz, F., Weihe, E., Manthey, J. and Kubler, W. (1984) Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation, 69, pp. 1-7.
36. Treasure, C. B., Klein, J. L., Vita, J. A., Manoukian, S. V., Renwick, G. H. and Selwyn, A. P. (1993) Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation, 87, pp. 86-93.
37. Wilson, R. F., Laughlin, D. E., Ackell, P. H., Chilian, W. M., Holida, M. D. and Hartley, C. J. (1985) Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation, 72, pp. 82-92.
38. Galderisi, M., Cicala, S., D'Errico, A., de Divitiis, O. and de Simone, G. (2004) Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens, 22, pp. 2201-2208.